Lupin informs about press release

08 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding launch of Rocuronium Bromide Injection, 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) Multiple-Dose Vials, on receipt of U.S. FDA approval to the Company’s alliance partner Caplin Steriles for its ANDA. 

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2100.65 -11.35 (-0.54%)
01-Jan-2026 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.10
Dr. Reddys Lab 1250.00
Cipla 1499.50
Zydus Lifesciences 913.15
Lupin 2100.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×